Skip to main content
S

SCL Science Inc. — Investor Relations & Filings

Ticker · 246960 ISIN · KR7246960009 KO Professional, scientific and technical activities
Open in API
Filings indexed 310 across all filing types
Latest filing 2020-10-14 Regulatory Filings
Country KR South Korea
Listing KO 246960

About SCL Science Inc.

https://sclscience.com/en

SCL Science Inc., formerly InnoTherapy Inc., is a healthcare company focused on digital innovation and advanced medical technologies. The company develops and commercializes medical hemostatic agents based on its proprietary biomimetic technology, including the Bio-inspired Medical Materials (BiMM) product line. Leveraging 40 years of expertise in medical science, SCL Science is also dedicated to building a digital healthcare ecosystem using artificial intelligence and high-quality medical data. Its services extend to clinical trial analysis, bio-logistics, and an expanding drug discovery platform focused on AI-driven cancer vaccine development. The company serves hospitals, research laboratories, and other medical institutions.

Recent filings

Filing Released Lang Actions
기타경영사항(특허권취득)(자율공시)(아데노연관바이러스용 안정화제 및 이를 이용한 아데노연관바이러스의 안정화 방법)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from a Korean company (InnoTherapy) announcing the acquisition of a patent. It is categorized as a 'voluntary disclosure' (자율공시) regarding 'other management matters' (기타 경영사항). Since it does not fit into specific categories like financial reports, M&A, or director dealings, and is a standard regulatory announcement of a corporate event, it falls under the RNS (Regulatory Filings) category.
2020-10-14 Korean
기타경영사항(특허권취득)(자율공시)(지혈용 기구 및 이의 제조방법)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by InnoTherapy. It details the patent name, content, and application plan. Since it does not fit into specific categories like financial reports, M&A, or governance, and is a standard regulatory disclosure of corporate events, it falls under the RNS (Regulatory Filings) category.
2020-10-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (stock-backed loan extensions) of a major shareholder. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-09-21 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '이노테라피' covering the period from January 1, 2020, to June 30, 2020. It contains detailed financial statements, business descriptions, capital changes, and management information. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. H1 2020
2020-08-14 Korean
투자판단관련주요경영사항(체외용 지혈용품(InnoSEAL)의 말레이시아 품목허가 신청)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from a Korean company (InnoTherapy) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically the application for medical device approval in Malaysia. This type of disclosure is a standard regulatory announcement for material events that do not fall into specific categories like financial reports or shareholder meetings. Therefore, it is classified as a Regulatory Filing (RNS).
2020-07-20 Korean
투자판단관련주요경영사항(체외용 지혈용품(InnoSEAL) 아르헨티나 식품의약품관리청(ANMAT) 품목허가 승인)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from the company InnoTherapy regarding the approval of a medical product (InnoSEAL) by the Argentine regulatory authority (ANMAT). It is a standard corporate disclosure of a material event (major management decision/business development) that does not fit into specific categories like financial reports, dividends, or share transactions. Therefore, it is classified as a general regulatory filing.
2020-07-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.